Mоlimо vаs kоristitе оvај idеntifikаtоr zа citirаnjе ili оvај link dо оvе stаvkе: https://open.uns.ac.rs/handle/123456789/2557
Nаziv: Epidemiological data of ovarian cancer in vojvodina and south great plain region in Hungary in 2007-2012 period: Crossbiomark IPA PROJECT HUSRB/1203/214/091
Аutоri: Aljoša Mandić 
Laszlo Thurzó
Dejan Ninčić
Milica Živaljević
Tihomir Dugandžija 
Robert Berkecz
Ključnе rеči: Ovarian Neoplasm;Epidemiology;Neoplasm Staging
Dаtum izdаvаnjа: 1-јан-2013
Čаsоpis: Archive of Oncology
Sažetak: © 2013, Oncology Institute of Vojvodina, Sremska Kamenica. Background: Ovarian cancer is among the sixth leading cancers in Vojvodina and the fifth leading cause of cancer death among female population in Vojvodina according to Cancer Registry of Vojvodina in 2010. The majority of ovarian cancers cases are diagnosed at an advanced stage, FIGO stage III-IV with poor prognosis. The aim of the study was to evaluate newly diagnosed ovarian cancer among female population in Vojvodina (Serbia) and South Great Plain region in Hungary in 2007-2012 period. Methods: The evaluation was based on the data from hospital registries for malignant diseases at the Oncology Institute of Vojvodina and the Department of Oncotherapy, University of Szeged. Results: The majority of patients were diagnosed in advanced disease (FIGO stage III-IV) in both regions. Serous epithelial ovarian cancer was the most common cancer type among studied women in both regions. The average age of women diagnosed with ovarian cancer was 60 years; there was no significant statistical difference related to patients’ age in both studied regions. Advanced stage of ovarian cancer investigated in our study showed a moderate descending liner trend with no significant statistical difference. The results from our study were similar when compared with the epidemiological data from the literature. Conclusion: The lack of efficient screening methods is the major obstacle to improve the prognosis of women affected by this disease. Further investigations and introduction of new technologies applied to medical discoveries offers new hope for finding effective screening policies.
URI: https://open.uns.ac.rs/handle/123456789/2557
ISSN: 3547310
DOI: 10.2298/AOO1304097M
Nаlаzi sе u kоlеkciјаmа:MDF Publikacije/Publications

Prikаzаti cеlоkupаn zаpis stаvki

SCOPUSTM   
Nаvоđеnjа

1
prоvеrеnо 20.05.2023.

Prеglеd/i stаnicа

38
Prоtеklа nеdеljа
9
Prоtеkli mеsеc
10
prоvеrеnо 10.05.2024.

Google ScholarTM

Prоvеritе

Аlt mеtrikа


Stаvkе nа DSpace-u su zаštićеnе аutоrskim prаvimа, sа svim prаvimа zаdržаnim, оsim аkо nije drugačije naznačeno.